Trial Details

Not Recruiting
Basic Information
Clinical ID c3315
Identifier EUCTR2008-005903-25-DE
Trial Title Exploratory, open-label study to demonstrate efficacy, safety and tolerability of SC12267 (35 mg) in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis)
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions inflammatory bowel disease (Crohn's disease and ulcerative colitis) MedDRA version: 12.0_Level: LLT_Classification code 10021973_Term: Inflammatory bowel disease NOS_
Interventions Product Name: SC12267 Product Code: SC12267 Pharmaceutical Form: Film-coated tablet Current Sponsor code: SC12267 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 35- Trade Name: Prednisolon Jenapharm Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Prednisolon CAS Number: 50-24-8 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5- Trade Name: Prednisolon Jenapharm Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Prednisolon CAS Number: 50-24-8 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- Trade Name: Prednisolon Jenapharm Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Prednisolon CAS Number: 50-24-8 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 20-
Participant Information
Sponsor 4SC AG
City -
Country/Region Bulgaria;Germany
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -